Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apical myocardial fibrosis burden identifies a high-risk phenotype and predicts cardiac mortality after LVAD implantation.

ESC heart failure - 5 May 2026

Demir İbrahim, Ecemiş Bilge, Zorba Ayşe, Barış Işık İkbal, Keskin Berhan, Cantürk Emir, Yıldız Yahya, Karaca İbrahim Oğuz, Erkanlı Korhan

Abstract excerpt

INTRODUCTION: Advanced heart failure is characterized by progressive myocardial remodelling, with fibrosis representing a final common pathway of chronic injury. We investigated whether quantitatively assessed apical myocardial fibrosis burden at the time of left ventricular assist device (LVAD) implantation is associated with overall and cause-specific mortality. METHODS: This single-centre retrospective cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathies
Share to Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Failure

Share to Heart Ventricles

Share to Myocardium

Share to Risk Assessment

Share to Survival Rate

Share to Ventricular Remodeling

Source

Open in PubMed Open full text

Identifiers

PMID: 42117772
DOI: 10.1093/eschf/xvag135
PMCID: PMC13195508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apical myocardial fibrosis burden identifies a high-risk phenotype and predicts cardiac mortality after LVAD implantation.PMID 42117772Read ↗

Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME Consortium.Semantic proximity Read ↗

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipientsSemantic proximity Read ↗

The Role of Interleukin-6 in Predicting Adverse Cardiac Outcomes in Asian Hypertrophic CardiomyopathySemantic proximity Read ↗

Reverse remodelling and myocardial recovery in heart failure.Semantic proximity Read ↗

End-stage valvular heart disease requiring heart transplantation: risk profile, surgical modifiers, and myocardial pathology.Semantic proximity Read ↗

Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations.Semantic proximity Read ↗

Misperception in Heart Failure Phenotyping: Moving Beyond the Chamber to the Myocardium.Semantic proximity Read ↗

Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes.Semantic proximity Read ↗

Extracellular matrix and cytoskeletal reverse remodeling pathways are key drivers of myocardial recovery following left ventricular assist device therapySemantic proximity Read ↗

Integrative Clinical–Molecular Modeling Identifies <i>LRRN4CL</i> as a Determinant of Structural and Functional Myocardial ImprovementSemantic proximity Read ↗

The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.Semantic proximity Read ↗

Patient-specific <i>in silico</i> prediction of outcomes of partial continuous-flow LVAD treatment in peripartum cardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.